Biomarker for monitoring development of diseases and assessing the efficacy of therapies
US8975081B2 · kind B2 · utility
1Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2013 |
| Grant date | Mar 10, 2015 |
| Priority date | — |
| Expiry date | Mar 9, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention concerns a method for monitoring the development of a disease in a patient, and for assessing the efficacy of a therapy influencing on the CD73 level or activity in the patient, in particular a cytokine therapy or a statin therapy. CD73 in a tissue fluid drawn from the patient is used as a biomarker. The invention concerns also methods for determining of CD73 protein in a sample drawn from an individual's tissue fluid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.